Wentao Pharmaceuticals completes tens of millions of A round of strategic financing

Wentao Pharmaceuticals is a clinical drug developer, focusing on the development and production of innovative drugs and generic drugs. Its innovative projects include new molecular entity innovative drugs and improved new drugs, which are suitable for the prevention of myocardial infarction, stable or unstable angina pectoris and cancer field of treatment. Recently, Wentao Pharmaceuticals completed tens of millions of RMB in Series A financing. The investor is Heda Capital. FA is Taishan Hui Capital.

This article is reproduced from: https://www.itjuzi.com/investevent/13408860
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment

Your email address will not be published.